These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 140543)

  • 41. Doxorubicin and vincristine with methionine depletion contributed to survival in the Yoshida sarcoma bearing rats.
    Nagahama T; Goseki N; Endo M
    Anticancer Res; 1998; 18(1A):25-31. PubMed ID: 9568051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A phase I trial of high-dose continuous-infusion hydroxyurea.
    Smith DC; Vaughan WP; Gwilt PR; Trump DL
    Cancer Chemother Pharmacol; 1993; 33(2):139-43. PubMed ID: 8261572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hydroxyurea-induced HbF production in anemic primates: augmentation by erythropoietin, hematopoietic growth factors, and sodium butyrate.
    McDonagh KT; Dover GJ; Donahue RE; Nathan DG; Agricola B; Byrne E; Nienhuis AW
    Exp Hematol; 1992 Nov; 20(10):1156-64. PubMed ID: 1385194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats.
    Widder KJ; Morris RM; Poore GA; Howard DP; Senyei AE
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):135-9. PubMed ID: 6682771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The cancerostatic effects of some isothiocyanates on nitrogen mustard-sensitive and -resistant lines of Yoshida sarcoma.
    Miko M; Ujházy V
    Neoplasma; 1968; 15(4):357-63. PubMed ID: 5684461
    [No Abstract]   [Full Text] [Related]  

  • 46. An in vivo study on the synchronizing effect of hydroxyurea.
    Maurer-Schultze B; Siebert M; Bassukas ID
    Exp Cell Res; 1988 Jan; 174(1):230-43. PubMed ID: 3335224
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synchronization of L1210 leukemia with hydroxyurea infusion and the effect of subsequent pulse dose chemotherapy.
    Moran RE; Straus MJ
    Cancer Treat Rep; 1980 Jan; 64(1):81-6. PubMed ID: 7379059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Shifting in cell cycle of transplantation tumors. Cytophotometrical investigations (author's transl)].
    Stöhr M; Gehrig HD; Löhrke H; Petrova L
    Virchows Arch B Cell Pathol; 1973 Dec; 14(3):247-58. PubMed ID: 4358916
    [No Abstract]   [Full Text] [Related]  

  • 49. [On the electrolyte changes in serum and ascites during cytostatic therapy of transplanted tumors].
    Asbach HW
    Arzneimittelforschung; 1968 Sep; 18(9):1180-2. PubMed ID: 5755934
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of x-ray radiation and mitomycin C administration on cell cycle of Yoshida sarcoma.
    Hirai E; Kato T; Tobe T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1968 Oct; 28(7):980-5. PubMed ID: 5249684
    [No Abstract]   [Full Text] [Related]  

  • 51. Phase I clinical trial of parenteral hydroxyurea in combination with pelvic and para-aortic external radiation and brachytherapy for patients with advanced squamous cell cancer of the uterine cervix.
    Beitler JJ; Anderson P; Haynes H; Sood B; Fields A; Goldberg G; Vikram B; Runowicz CD; Wadler S
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):637-42. PubMed ID: 11849784
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hydroxyurea effects in the C3H mouse. I. Duodenal crypt cell kinetics.
    Dethlefsen LA; Riley RM
    Cell Tissue Kinet; 1973 Jan; 6(1):3-16. PubMed ID: 4683347
    [No Abstract]   [Full Text] [Related]  

  • 53. Schedule dependent inhibition of thymidylate synthase and tumor growth by 5-fluorouracil in Yoshida sarcoma bearing rats.
    Tsujinaka T; Kido Y; Shiozaki H; Mori T
    J Surg Oncol; 1992 Jul; 50(3):190-4. PubMed ID: 1619944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Synchronization of the cell cycle in solid tumors].
    Matsuzawa D; Nakayama T; Morita H
    Gan No Rinsho; 1971 May; 17(5):344-7. PubMed ID: 5104742
    [No Abstract]   [Full Text] [Related]  

  • 55. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway.
    Schrell UM; Rittig MG; Anders M; Kiesewetter F; Marschalek R; Koch UH; Fahlbusch R
    J Neurosurg; 1997 May; 86(5):845-52. PubMed ID: 9126901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell kinetics-dependent antitumor effect of irinotecan hydrochloride induced by the synchronizing effect of hydroxyurea: cell kinetics and dosing time.
    Akagi T; Ushinohama K; Kage Y; Ishizaki T; Makinosumi T; Yamauchi A; Taguchi Y; Inoue K; Yukawa E; Higuchi S; Ohdo S
    Life Sci; 2003 Jan; 72(10):1183-97. PubMed ID: 12505548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cisplatin with high-dose infusions of hydroxyurea to inhibit DNA repair. A phase II study in non-small-cell lung cancer.
    Cantwell BM; Veale D; Rivett C; Ghani S; Harris AL
    Cancer Chemother Pharmacol; 1989; 23(4):252-4. PubMed ID: 2538251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The effect of misonidazole on anti-tumor activity of immunized rats that received total body irradiation (author's transl)].
    Mitsuhashi N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981 Dec; 41(12):1209-12. PubMed ID: 7041081
    [No Abstract]   [Full Text] [Related]  

  • 59. Chromosomal studies with the nitrogen mustard-sensitive and resistant Yoshida tumour.
    Ujházy V
    Neoplasma; 1968; 15(6):657-61. PubMed ID: 5704185
    [No Abstract]   [Full Text] [Related]  

  • 60. Oral cyclophosphamide and oral hydroxyurea in the treatment of hormone refractory prostate cancer in rats.
    Naik H; Lehr J; Akhtar A; Pienta K
    Anticancer Res; 1994; 14(6B):2681-4. PubMed ID: 7872701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.